DarioHealth Corp. (DRIO)

Market Cap	28.80M
Revenue (ttm)	23.05M
Net Income (ttm)	-32.30M
Shares Out	34.10M
EPS (ttm)	-0.88
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	161,908
Open	0.830
Previous Close	0.830
Day's Range	0.800 - 0.923
52-Week Range	0.705 - 2.600
Beta	1.51
Analysts	Strong Buy
Price Target	4.00 (+373.49%)
Earnings Date	Nov 7, 2024

About DRIO

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, wh...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2011
• Employees: 294
• Stock Exchange: NASDAQ
• Ticker Symbol: DRIO
• Website: https://www.dariohealth.com

Financial Performance

In 2023, DarioHealth's revenue was $20.35 million, a decrease of -26.41% compared to the previous year's $27.66 million. Losses were -$54.86 million, -8.50% less than in 2022.

Analyst Forecast

According to one analyst, the rating for DRIO stock is "Strong Buy" and the 12-month stock price forecast is $4.0.

Price Target

$4.0

(373.49% upside)

Analyst Consensus: Strong Buy